Pierre Regent Leblanc, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 3 | 2019 | 41 | 0.800 |
Why?
|
HSP70 Heat-Shock Proteins | 3 | 2018 | 396 | 0.610 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2015 | 65 | 0.500 |
Why?
|
Avidin | 1 | 2014 | 42 | 0.460 |
Why?
|
Communicable Diseases, Emerging | 2 | 2014 | 148 | 0.460 |
Why?
|
Lassa Fever | 1 | 2014 | 96 | 0.420 |
Why?
|
Parkinson Disease | 5 | 2023 | 2867 | 0.330 |
Why?
|
Viral Vaccines | 1 | 2014 | 593 | 0.310 |
Why?
|
Antibodies | 1 | 2015 | 2415 | 0.280 |
Why?
|
Drug Discovery | 2 | 2016 | 1048 | 0.250 |
Why?
|
Drug Approval | 1 | 2012 | 812 | 0.240 |
Why?
|
Bacterial Proteins | 2 | 2014 | 3836 | 0.220 |
Why?
|
Vaccines | 1 | 2012 | 835 | 0.220 |
Why?
|
Pluripotent Stem Cells | 2 | 2022 | 794 | 0.210 |
Why?
|
Aphakia | 1 | 2022 | 26 | 0.200 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2023 | 370 | 0.200 |
Why?
|
Dopamine | 4 | 2023 | 1601 | 0.190 |
Why?
|
Sirtuin 2 | 1 | 2021 | 94 | 0.190 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2023 | 1852 | 0.190 |
Why?
|
Dynamins | 1 | 2021 | 139 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 471 | 0.170 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2021 | 332 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 475 | 0.170 |
Why?
|
Cancer Vaccines | 2 | 2018 | 1038 | 0.160 |
Why?
|
Antibody Specificity | 3 | 2015 | 1059 | 0.150 |
Why?
|
Chloroquine | 1 | 2019 | 274 | 0.150 |
Why?
|
Influenza Vaccines | 2 | 2017 | 767 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 3 | 2018 | 3726 | 0.150 |
Why?
|
Injections, Intradermal | 1 | 2017 | 116 | 0.140 |
Why?
|
Lasers, Semiconductor | 1 | 2017 | 41 | 0.140 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2019 | 501 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 245 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2023 | 3092 | 0.130 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 470 | 0.130 |
Why?
|
Staphylococcal Protein A | 1 | 2015 | 39 | 0.130 |
Why?
|
Immobilized Proteins | 1 | 2015 | 24 | 0.130 |
Why?
|
Antiparkinson Agents | 1 | 2016 | 184 | 0.120 |
Why?
|
Fibroblasts | 2 | 2022 | 4138 | 0.120 |
Why?
|
Chromatography, Affinity | 1 | 2015 | 525 | 0.120 |
Why?
|
HLA-DR3 Antigen | 1 | 2014 | 24 | 0.120 |
Why?
|
Immunomodulation | 1 | 2018 | 548 | 0.110 |
Why?
|
Cross Reactions | 1 | 2015 | 819 | 0.110 |
Why?
|
Lassa virus | 1 | 2014 | 98 | 0.110 |
Why?
|
Vaccination | 2 | 2017 | 3369 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2455 | 0.110 |
Why?
|
Graft Survival | 1 | 2023 | 3843 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1140 | 0.100 |
Why?
|
Infrared Rays | 1 | 2013 | 248 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.100 |
Why?
|
Ovalbumin | 1 | 2014 | 671 | 0.100 |
Why?
|
Mesothelioma | 1 | 2018 | 807 | 0.100 |
Why?
|
Immunocompetence | 1 | 2011 | 138 | 0.090 |
Why?
|
Orthomyxoviridae Infections | 1 | 2013 | 254 | 0.090 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2011 | 74 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1044 | 0.090 |
Why?
|
Mesencephalon | 2 | 2023 | 332 | 0.090 |
Why?
|
Quinolines | 1 | 2016 | 764 | 0.090 |
Why?
|
Influenza A virus | 1 | 2013 | 458 | 0.090 |
Why?
|
Protein Engineering | 1 | 2014 | 546 | 0.090 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 447 | 0.080 |
Why?
|
RNA Splice Sites | 1 | 2011 | 210 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1600 | 0.080 |
Why?
|
Lasers | 1 | 2013 | 952 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 454 | 0.080 |
Why?
|
Lymph Nodes | 2 | 2011 | 3461 | 0.080 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2011 | 914 | 0.080 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 988 | 0.080 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2011 | 394 | 0.080 |
Why?
|
Norepinephrine | 1 | 2011 | 897 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9520 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2244 | 0.070 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2011 | 541 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 1985 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 727 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 22128 | 0.060 |
Why?
|
Simian immunodeficiency virus | 1 | 2011 | 810 | 0.060 |
Why?
|
Animals | 14 | 2023 | 168089 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2014 | 3155 | 0.060 |
Why?
|
Mice | 9 | 2023 | 81330 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18222 | 0.060 |
Why?
|
Spleen | 1 | 2009 | 2290 | 0.050 |
Why?
|
Oxidopamine | 1 | 2023 | 172 | 0.050 |
Why?
|
Cell Death | 2 | 2023 | 1676 | 0.050 |
Why?
|
Cricetulus | 2 | 2018 | 812 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1912 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2047 | 0.050 |
Why?
|
CHO Cells | 2 | 2018 | 1379 | 0.050 |
Why?
|
Neostriatum | 1 | 2023 | 247 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3754 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4404 | 0.050 |
Why?
|
Levodopa | 1 | 2022 | 222 | 0.050 |
Why?
|
Rats | 3 | 2023 | 23705 | 0.050 |
Why?
|
Cricetinae | 2 | 2018 | 2412 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4373 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 2014 | 3841 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27094 | 0.040 |
Why?
|
Substantia Nigra | 1 | 2022 | 347 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 495 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3875 | 0.040 |
Why?
|
Putamen | 1 | 2020 | 292 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1050 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2022 | 11512 | 0.040 |
Why?
|
Mitochondria | 2 | 2022 | 3620 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5775 | 0.040 |
Why?
|
Glycolysis | 1 | 2021 | 836 | 0.040 |
Why?
|
Basal Ganglia | 1 | 2020 | 554 | 0.040 |
Why?
|
Benzylamines | 1 | 2018 | 247 | 0.030 |
Why?
|
Immunotherapy | 1 | 2012 | 4642 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2011 | 12747 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2112 | 0.030 |
Why?
|
Humans | 16 | 2023 | 761222 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2621 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2014 | 66 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4872 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1756 | 0.030 |
Why?
|
Th17 Cells | 1 | 2019 | 794 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2022 | 2414 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2023 | 10423 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2022 | 5871 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1356 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4822 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1703 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2021 | 2877 | 0.020 |
Why?
|
Gene Products, gag | 1 | 2011 | 312 | 0.020 |
Why?
|
Female | 8 | 2022 | 392552 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2740 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2175 | 0.020 |
Why?
|
Cryoprotective Agents | 1 | 2011 | 128 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 546 | 0.020 |
Why?
|
Glycerol | 1 | 2011 | 275 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3770 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 487 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3596 | 0.020 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2011 | 268 | 0.020 |
Why?
|
Chemotaxis | 1 | 2011 | 598 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2014 | 1783 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2011 | 659 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1602 | 0.020 |
Why?
|
Time Factors | 2 | 2023 | 39957 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 30004 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8519 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20982 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1958 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1126 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2011 | 2328 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3803 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2023 | 64681 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6586 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 1249 | 0.010 |
Why?
|
HIV Infections | 1 | 2009 | 17348 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13402 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2816 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12101 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10203 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17598 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16954 | 0.010 |
Why?
|
Antigens, CD | 1 | 2011 | 4009 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4473 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10759 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39127 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13511 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12728 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20588 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23419 | 0.010 |
Why?
|
Male | 3 | 2022 | 360703 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9478 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9319 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2014 | 8606 | 0.010 |
Why?
|
Aged | 2 | 2020 | 169292 | 0.010 |
Why?
|
Neoplasms | 1 | 2014 | 22142 | 0.000 |
Why?
|
Middle Aged | 1 | 2009 | 220858 | 0.000 |
Why?
|